Mei Wei, MD, an oncologist specializing in breast cancer at Huntsman Cancer Institute at the University of Utah, discusses new treatments for HR+/HER2- breast cancer and immunotherapy challenges, ...

Under this two-hit model, Brugge says, one normal copy of BRCA1 ought to be able to carry out DNA repair even when the other ...

Researchers also are trying to understand the racial disparities in breast cancer diagnosis and mortality. Black women have a lower survival rate for breast cancer than white women, no matter the ...

Scientists at the Johns Hopkins Kimmel Cancer Center have identified 16 genes that breast cancer cells use to survive in the bloodstream after they've escaped the low-oxygen regions of a tumor.

Reported interim RLY-2608 data demonstrating 9.2-month median PFS in heavily pre-treated patients with PI3Kα-mutated, ...

In contrast to the prevailing belief that radical mastectomy was the best course of treatment for breast cancer patients, Fisher found that the two surgical techniques had equal survival rates.

Kisqali (ribociclib) given alongside endocrine therapy as adjuvant therapy for patients with stage 2 or 3 hormone receptor-positive, HER2-negative breast cancer reduced patients’ risk for ...

Analyst Andrew Berens of Leerink Partners maintained a Buy rating on Relay Therapeutics (RLAY – Research Report), retaining the price ...

The new figures reveal that, despite a record £192billion spent on the NHS this year, the UK has one of the worst cancer mortality rates globally, coming 123rd out of 185 nations. Both the US ...